Stock IdeasStrong Buy StocksStrong Buy Stocks from Top Wall Street AnalystsLatest stocks with a Strong Buy rating from the top performing 25% of analysts tracked by WallStreetZen
Stock IdeasStrong Buy Stocks
| Analyst / Firm | Company | Price | Rating | Price Target | Upside/Downside | Date |
|---|---|---|---|---|---|---|
Eyepoint IncEYPT | $13.20 | Strong Buy | $65.00 | +392.61% | 21 hours ago | |
Analyst RankingTop 8% #413 out of 5313 analysts Average Return+19.59% Win Rate52%60 out of 116 Risk vs RewardPoor Good Analyst ColorChardan Capital's Andreas Argyrides raised their price target on Eyepoint (NASDAQ: EYPT) by 124.1% from $29 to $65 on 2026/07/01. The analyst maintained their Strong Buy rating on the stock. Assuming coverage with a price target raise, Argyrides called EyePoint "a de-risked, single-asset, catalyst-rich story" heading into pivotal readouts from Phase 3 studies of DURAVYU in wet AMD expected in 2028/08 and 2026/10this year. The analyst reminded readers that the company's two largest retinal markets (wet AMD and DME) represent $13B in U.S. sales next year. | ||||||
Tesla IncTSLA | $800.00 | Strong Buy | $850.00 | +6.25% | a day ago | |
Upgrade to Premium to View MoreStrong buys: Upgrade to Premium to view the rest of today's Strong Buy stocks from Wall Street's top analysts Already have access to Premium? Sign In | ||||||
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.